Scholarlink

Purpose <p>Cardiovascular-kidney-metabolic (CKM) syndrome is a newly recognized multisystem disorder, with over 90% of cases occurring in the early stages (0–3). However, there is a lack of evidence for dietary interventions during this phase. This study is the first to examine the connection between the composite dietary antioxidant index (CDAI) and mortality risk in early-stage CKM patients, aiming to support early intervention strategies based on nutrition.</p> Methods <p>We analyzed data from 7,642 CKM 0–3 stage patients from the NHANES 2007–2018 cohort. Multivariable weighted Cox regression was used to assess the association between CDAI and all-cause/cardiovascular disease (CVD) mortality. A restricted cubic spline was applied to explore dose-response relationships, with subgroup analyses to explore population heterogeneity.</p> Results <p>During a median follow-up of 94 months, 594 all-cause deaths and 151 CVD deaths were recorded. Each unit increase in CDAI was substantially linked to a 6% decrease in all-cause mortality after controlling for covariates (HR = 0.94, 95% CI 0.91–0.98). Mortality risk was 40% lower in the highest CDAI quartile than in the lowest quartile (HR = 0.60, 95% CI 0.44–0.83). Dose-response analysis revealed a linear decreasing trend (<i>p</i> &lt; 0.001). Subgroup analyses further supported these findings. Carotenoids and vitamin E were also substantially linked to a decreased all-cause mortality rate in CKM patients. For CVD mortality, a significant association was observed in unadjusted models (HR = 0.92, 95% CI 0.86–0.98, <i>P</i> &lt; 0.05), but no significant association was found between CDAI and CVD mortality in the fully adjusted model (HR = 0.98, 95% CI 0.92–1.05, <i>P</i> = 0.62), suggesting potential mediation by covariates such as comorbidities and lifestyle factors.</p> Conclusion <p>Enhanced dietary antioxidant capacity significantly reduces all-cause mortality risk in early-stage CKM patients (stages 0–3), with vitamin E and carotenoids potentially playing key protective roles. These findings provide dose-response evidence for early nutritional interventions in CKM syndrome, suggesting that multi-nutrient strategies targeting oxidative stress pathways may offer new directions for prevention and management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dietary antioxidants and mortality in early-stage CKM syndrome: insights from NHANES

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月16日

查看全文
  • Lincheng Duan,
  • Hong Yang,
  • Zhuoyang Chen,
  • Junxin Zhao,
  • Jingyi Yang,
  • Dingjun Cai

摘要

Purpose

Cardiovascular-kidney-metabolic (CKM) syndrome is a newly recognized multisystem disorder, with over 90% of cases occurring in the early stages (0–3). However, there is a lack of evidence for dietary interventions during this phase. This study is the first to examine the connection between the composite dietary antioxidant index (CDAI) and mortality risk in early-stage CKM patients, aiming to support early intervention strategies based on nutrition.

Methods

We analyzed data from 7,642 CKM 0–3 stage patients from the NHANES 2007–2018 cohort. Multivariable weighted Cox regression was used to assess the association between CDAI and all-cause/cardiovascular disease (CVD) mortality. A restricted cubic spline was applied to explore dose-response relationships, with subgroup analyses to explore population heterogeneity.

Results

During a median follow-up of 94 months, 594 all-cause deaths and 151 CVD deaths were recorded. Each unit increase in CDAI was substantially linked to a 6% decrease in all-cause mortality after controlling for covariates (HR = 0.94, 95% CI 0.91–0.98). Mortality risk was 40% lower in the highest CDAI quartile than in the lowest quartile (HR = 0.60, 95% CI 0.44–0.83). Dose-response analysis revealed a linear decreasing trend (p < 0.001). Subgroup analyses further supported these findings. Carotenoids and vitamin E were also substantially linked to a decreased all-cause mortality rate in CKM patients. For CVD mortality, a significant association was observed in unadjusted models (HR = 0.92, 95% CI 0.86–0.98, P < 0.05), but no significant association was found between CDAI and CVD mortality in the fully adjusted model (HR = 0.98, 95% CI 0.92–1.05, P = 0.62), suggesting potential mediation by covariates such as comorbidities and lifestyle factors.

Conclusion

Enhanced dietary antioxidant capacity significantly reduces all-cause mortality risk in early-stage CKM patients (stages 0–3), with vitamin E and carotenoids potentially playing key protective roles. These findings provide dose-response evidence for early nutritional interventions in CKM syndrome, suggesting that multi-nutrient strategies targeting oxidative stress pathways may offer new directions for prevention and management.